Visitors walk at the historical Grand Bazaar in Istanbul on July 9, 2024. (Photo by Yasin AKGUL / AFP)
Istanbul, Turkey — Annual inflation slowed in Turkey in January for the eighth consecutive month, official figures showed Monday.
Consumer prices rose by 42.1 percent year-on-year, compared with 44.3 percent a month earlier, figures from Turkey’s TUIK statistics institute said.
Article continues after this advertisementTurkey has experienced double-digit inflation since 2019, making life increasingly more expensive for millions of people, notably hitting the cost of education, housing, healthcare and restaurants and hotels.
FEATURED STORIES BUSINESS BIZ BUZZ: Age just a number at KFC BUSINESS Mixed fuel price adjustments set on Tuesday, February 4 BUSINESS US tariffs: A blow to the world economyREAD: Turkey’s central bank lowers benchmark interest rate to 45%
The annual rate peaked at 75 percent in May before starting to ease from June.
Article continues after this advertisementOn January 23, Turkey’s central bank lowered its key interest rate to 45 percent from 50 percent in December, saying its efforts to tame sky-high inflation were starting to pay off.
Article continues after this advertisementThe monthly inflation accelerated to five percent in January, compared to one percent the previous month, TUIK data showed.
Article continues after this advertisementFinance Minister Mehmet Simsek said the increase was due to “seasonal effects” and vowed inflation would keep on falling down, in a message on X.
William Jackson, chief emerging markets economist at London-based Capital Economics, said in a policy note that a jump in monthly inflation was “always likely” given the minimum wage hike hike around the turn of the year.
Article continues after this advertisementThe net monthly minimum wage has been raised by 30 percent to 22,104 lira ($600), beginning from January 1.
The official inflation figures are disputed by the ENAG group of independent economists, which publishes its own monthly figures and gave a January year-on-year estimate of 81 percent.
WASHINGTON, United States — US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.
Subscribe to our daily newsletter
free real money casino no deposit